Autonomix Medical (AMIX) Return on Capital Employed (2024 - 2025)

Autonomix Medical (AMIX) reported Return on Capital Employed of 236.48% for Q4 2025, down 20591.0% year-over-year from N/an in Q4 2024, and up 2.68% quarter-over-quarter from 242.98% in Q3 2025.

Autonomix Medical (AMIX) Return on Capital Employed (2024 - 2025) Analysis & Trends

Autonomix Medical (AMIX) has 2 years of Return on Capital Employed data on file, last reported at 236.48% in Q4 2025.

  • Return on Capital Employed for Q4 2025 came in at 236.48%, down 20591.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 236.48% (down 20591.0% YoY), and the FY2025 annual result was 146.69%, down 7239.0% from the prior year.
  • Return on Capital Employed advanced to 236.48% in Q4 2025 per AMIX's latest filing, from 242.98% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 30.56% in Q4 2024 and troughed at 242.98% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 9.61%
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 12.24%
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 7.36%
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 9.62%
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 11.13%
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 9.30%
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 10.45%
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 24.24%
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 11.57%
10 Autonomix Medical 3.33 Mn 3.33 Mn - -236.48%

Historic Data

Download Data
DateValue
Dec 31, 2025 -236.48%
Sep 30, 2025 -242.98%
Jun 30, 2025 -164.81%
Mar 31, 2025 -126.34%
Dec 31, 2024 -30.56%
Sep 30, 2024 -42.97%
Jun 30, 2024 -68.40%
Mar 31, 2024 -67.07%